Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 634

1.

Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells.

Gawlik-Rzemieniewska N, Galilejczyk A, Krawczyk M, Bednarek I.

Arch Med Sci. 2016 Aug 1;12(4):889-97. doi: 10.5114/aoms.2015.55368. Epub 2015 Nov 4.

2.

Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment.

Polireddy K, Chen Q.

J Cancer. 2016 Jul 7;7(11):1497-514. doi: 10.7150/jca.14922. eCollection 2016. Review.

3.

The effect of salinomycin on ovarian cancer stem-like cells.

Chung H, Kim YH, Kwon M, Shin SJ, Kwon SH, Cha SD, Cho CH.

Obstet Gynecol Sci. 2016 Jul;59(4):261-8. doi: 10.5468/ogs.2016.59.4.261. Epub 2016 Jul 13.

4.

SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.

Kawai T, Yasuchika K, Ishii T, Miyauchi Y, Kojima H, Yamaoka R, Katayama H, Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Komori J, Hatano E, Kawaguchi Y, Uemoto S.

Sci Rep. 2016 Jul 26;6:30489. doi: 10.1038/srep30489.

5.

Stem-like features of cancer cells on their way to metastasis.

Gkountela S, Aceto N.

Biol Direct. 2016 Jul 26;11:33. doi: 10.1186/s13062-016-0135-4. Review.

6.

Walnut Phenolic Extract and Its Bioactive Compounds Suppress Colon Cancer Cell Growth by Regulating Colon Cancer Stemness.

Lee J, Kim YS, Lee J, Heo SC, Lee KL, Choi SW, Kim Y.

Nutrients. 2016 Jul 21;8(7). pii: E439. doi: 10.3390/nu8070439.

7.

Role of CD133+ cells in tongue squamous carcinomas: Characteristics of 'stemness' in vivo and in vitro.

Wang K, Zhou XK, Wu M, Kang FW, Wang ZL, Zhu Y.

Oncol Lett. 2016 Aug;12(2):863-870. Epub 2016 Jun 15.

8.

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?

Adeberg S, Harrabi SB, Bougatf N, Bernhardt D, Mohr A, Rieber J, Koelsche C, Rieken S, Debus J.

Stem Cells Int. 2016;2016:8793462. doi: 10.1155/2016/8793462. Epub 2016 Jun 27.

9.

Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.

Takaya A, Hirohashi Y, Murai A, Morita R, Saijo H, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Tamura Y, Takemasa I, Kondo T, Sato N, Torigoe T.

PLoS One. 2016 Jul 14;11(7):e0158903. doi: 10.1371/journal.pone.0158903. eCollection 2016.

10.

SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.

Lundberg IV, Edin S, Eklöf V, Öberg Å, Palmqvist R, Wikberg ML.

BMC Cancer. 2016 Jul 13;16:471. doi: 10.1186/s12885-016-2509-5.

11.

Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer.

Jahchan NS, Lim JS, Bola B, Morris K, Seitz G, Tran KQ, Xu L, Trapani F, Morrow CJ, Cristea S, Coles GL, Yang D, Vaka D, Kareta MS, George J, Mazur PK, Nguyen T, Anderson WC, Dylla SJ, Blackhall F, Peifer M, Dive C, Sage J.

Cell Rep. 2016 Jul 19;16(3):644-56. doi: 10.1016/j.celrep.2016.06.021. Epub 2016 Jun 30.

12.

Oncolytic virus as a cancer stem cell killer: progress and challenges.

Ding J.

Stem Cell Investig. 2014 Dec 28;1:22. doi: 10.3978/j.issn.2306-9759.2014.12.02. eCollection 2014. Review.

13.

Cancer stem cells as a potential therapeutic target in breast cancer.

Zhang M, Li Z, Zhang X, Chang Y.

Stem Cell Investig. 2014 Jul 16;1:14. doi: 10.3978/j.issn.2306-9759.2014.06.01. eCollection 2014. Review.

14.

Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells.

Warner SG, Haddad D, Au J, Carson JS, O'Leary MP, Lewis C, Monette S, Fong Y.

Mol Ther Oncolytics. 2016 Jun 15;3:16013. doi: 10.1038/mto.2016.13. eCollection 2016.

15.

Comparison of leucine-rich repeat-containing G protein-coupled receptor 5 expression in different cancer and normal cell lines.

Alizadeh-Navaei R, Rafiei A, Abedian-Kenari S, Asgarian-Omran H, Valadan R, Hedayatizadeh-Omran A.

Biomed Rep. 2016 Jul;5(1):130-132. Epub 2016 May 20.

16.

Biological characteristics of side population cells in a self-established human ovarian cancer cell line.

Wei Z, Lv S, Wang Y, Sun M, Chi G, Guo J, Song P, Fu X, Zhang S, Li Y.

Oncol Lett. 2016 Jul;12(1):41-48. Epub 2016 May 13.

PMID:
27347097
Free PMC Article
17.

Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.

He J, Zhou M, Chen X, Yue D, Yang L, Qin G, Zhang Z, Gao Q, Wang D, Zhang C, Huang L, Wang L, Zhang B, Yu J, Zhang Y.

J Exp Clin Cancer Res. 2016 Jun 21;35(1):98. doi: 10.1186/s13046-016-0378-z.

18.

Ultrasensitive proteomic quantitation of cellular signaling by digitized nanoparticle-protein counting.

Jacob T, Agarwal A, Ramunno-Johnson D, O'Hare T, Gönen M, Tyner JW, Druker BJ, Vu TQ.

Sci Rep. 2016 Jun 20;6:28163. doi: 10.1038/srep28163.

19.

Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications.

Ju HQ, Lu YX, Chen DL, Tian T, Mo HY, Wei XL, Liao JW, Wang F, Zeng ZL, Pelicano H, Aguilar M, Jia WH, Xu RH.

Theranostics. 2016 May 23;6(8):1160-75. doi: 10.7150/thno.14848. eCollection 2016.

20.

Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase.

Chung SS, Oliva B, Dwabe S, Vadgama JV.

Int J Oncol. 2016 Aug;49(2):487-98. doi: 10.3892/ijo.2016.3546. Epub 2016 May 31.

Items per page

Supplemental Content

Write to the Help Desk